Health Psychology Research / HPR / Volume 3 / Issue 1 / DOI: 10.4081/​hpr.2015.1556
GENERAL

Perception of pain self-efficacy  and fatigue in Greek patients  with multiple sclerosis: a study  protocol

Paraskevi Theofilou1* Vaitsa Giannouli2 Stergios Kolias2 Magda Tsolak2
Show Less
1 Sotiria Hospital for Thoracic Diseases, Athens
2 Third Neurology Department, School of Medicine, Aristotle University of Thessaloniki, Greece
Submitted: 1 April 2014 | Accepted: 7 April 2014 | Published: 13 April 2015
© 2015 by the Author(s). Licensee Health Psychology Research, USA. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution -Noncommercial 4.0 International License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/ )
Abstract

The examination of the perception of pain and fatigue in patients with various health problems has received increased research attention in recent years. The aim of the pres ent study protocol is to examine levels of pain self-efficacy and fatigue in a sample of Greek patients suffering from multiple sclerosis. The association of years and severity of diagnosis with the perception of pain self-efficacy and fatigue will be also investigated. Forty patients from the 3nd Neurological Department, Aristotle University of Thessaloniki (Greece) will participate in this study. The measure ment tools include i) the Fatigue Assessment Scale, ii) the Pain Self Efficacy Questionnaire and iii) the Expanded Disability Status Scale. Test-retest reliability of the first two question naires will be assessed with the same patients rating their situation in a 10 days interval from the first examination in order to examine con sistency over time.

Keywords
Pain; fatigue; pain self-efficacy; dis ability; multiple sclerosis
References

1. Moller A, Weidemann G, Rohde U. Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis. Actz Psychiatr Scand 1994;89:117-21.
2. Weinshenker BG. The natural history of Multiple Sclerosis. Neurol Clinic 1995;13:119-46.
3. Hauser SL. Multiple sclerosis and other demyelinating diseases. In: Harrison's principles of internal medicine. Isselbacher KJ, ed. New York: McGraw Hill; 1994. pp 2281-2294. 
4. Theofilou P. Quality of life, depression and fatigue in multiple sclerosis patients. J Nerol Neurophysiol. 2011;2:1-2. 
5. Brunet DG, Hopman WM, Singer MA, et al. Measurement of health-related quality of life in multiple sclerosis patients. Can J Neurol Sci 1996;23:99-103.
6. Fruewald S, Loeffler-Stastka H, Eher R, et al. Depression and quality of life in multiple sclerosis. Acta Neurol Scand 2001;104:257-61.
7. Kroencke DC, Denney DR, Lynch SG. Depression during exacerbations in multiple sclerosis: the importance of uncertainty. Mult Scler 2001;7:237-42.
8. Murphy N, Confavreux C, Haas J, et al. Quality of life in multiple sclerosis in France, Germany, and the United Kingdom. Cost of Multiple Sclerosis Study Group. J Neurol Neurosurg Psychiatry 1998;65:460-6.
9. Nortvedt MW, Riise T, Myhr KM, Nyland HI. Quality of life in multiple sclerosis: measuring the disease effects more broadly. Neurology 1999;53:1098-103.
10. Rothwell PM, McDowell Z, Wong CK, Dorman PJ. Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. BMJ 1997;314:1580-3.
11. Solari A, Radice D. Health status of people with multiple sclerosis: a community mail survey. Neurol Sci 2001;22:307-15.
12. The Canadian Burden of Illness Study Group. Burden of illness of multiple sclerosis: Part II: Quality of life. Can J Neurol Sci 1998;25:31-8.
13. Kraft GH, Freal JE, Coryell JK. Disability, disease duration, and rehabilitation service needs in multiple sclerosis: patient perspectives. Arch Phys Med Rehabil 1986;67:164-8.
14. Krupp LB, Alvarez LA, LaRocca NG, et al. Fatigue in multiple sclerosis. Arch Neurol 1988;45:435-7.
15. Hemmett L, Holmes J, Barnes M, et al. What drives quality of life in multiple sclerosis? QJM 2004;97:671-6.
16. Chaudhuri A, Behan PO. Fatigue in neurological disorders. Lancet 2004;363:978-88.
17. Giovannoni G. Multiple sclerosis related fatigue. J Neurol Neurosurg Psychiatry 2006;77:2-3.
18. Multiple Sclerosis Council for Clinical Practice Guidelines. Fatigue and multiple sclerosis: evidence based strategies for fatigue in multiple sclerosis. Washington: Paralyzed Veterans of America; 1998.
19. Bruno RL, Creange SJ, Frick NM. Parallels between post-polio fatigue and chronic fatigue syndrome: a common pathophysiology? Am J Med 1998;105:66S-73S.
20. Tartaglia MC, Narayanan S, Francis SJ, et al. The relationship between diffuse axonal damage and fatigue in multiple sclerosis. Arch Neurol 2004;61:201-7.
21. Rice CL, Vollmer TL, Bigland-Ritchie B. Neuromuscular responses of patients with multiple sclerosis. Muscle Nerve 1992;15:1123-32.
22. Olgiati R, Burgunder JM, Mumenthaler M. Increased energy cost of walking in multiple sclerosis: effect of spasticity, ataxia, and weakness. Arch Phys Med Rehabil 1988;69:846-9.
23. Krupp LB, Pollina DA. Mechanisms and management of fatigue in progressive neurological disorders. Curr Opin Neurol 1996;9:456-60.
24. Staub F, Bogousslavsky J. Is there such a thing as brain fatigue? Rev Neurol (Paris) 2001;157:259-62.
25. Bandura, A. Self-efficacy: the exercise of control. New York: Freeman; 1997.
26. Bodenheimer T, Lorig KR, Holman HR, Grumbach K. Patient self-management of chronic disease in primary care. J Am Med Assoc 2002;288;2469-75.
27. Lorig KR, Ritter PL, Stewart AL, et al. Chronic disease self-management program: 2-year health status and health care utilization outcomes. Med Care 2001;39:1217-23.
28. Lorig KR, Sobel DS, Ritter PL, et al. Effect of a self-management program for patients with chronic disease. Effect Clin Pract 2001;4:256-62.
29. Michielsen HJ, De Vries J, Van Heck GL. Psychometric qualities of a brief self rated fatigue measure: the Fatigue Assessment Scale. J Psychosom Res 2003;54:345-52.
30. Michielsen HJ, De Vries J, Van Heck G., et al. Examination of the dimensionality of fatigue: the construction of the Fatigue Assessment Scale (FAS). Eur J Psychol Assess 2004;20:39-48.
31. De Vries J, Michielsen HJ, Van Heck GL, Drent M. Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS). Br J Health Psychol 2004;9:279-91.
32. Michielsen HJ, De Vries J, Drent M, Peros Golubicic T. Psychometric qualities of the Fatigue Assessment Scale in Croatian sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 2005;22:133-8.
33. De Vries J, Michielsen HJ, Van Heck GL. Assessment of fatigue among working people: a comparison of six questionnaires. Occup Environ Med 2003;60:i10-i15.
34. Nicholas MK. Self-efficacy and chronic pain. Paper presented at the annual conference of the British Psychological Society. St. Andrews, 1989. Available from: https://www.worksafe.vic.gov.au/__data/assets/pdf_file/0020/10955/pain_self_efficacy_questionnaire.pdf
35. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.

Conflict of interest
The authors declare no potential conflict of interest.
Share
Back to top
Health Psychology Research, Electronic ISSN: 2420-8124 Published by Health Psychology Research